Some English words are more euphonious than others, and some are more cacophonic. Here I discuss the latter, the ugliest English words, of which I have analysed 415 from a large number of published ...

The BMA has agreed “in principle” to an £889m funding uplift to GPs’ contracts in England this year, on the condition that the government commits to negotiating a completely new national contract ...

Doctors who were incorrectly told they passed a crucial medical exam only to be told 18 months later that they had failed have now been told that their applications to higher specialty training this ...

Consultants at London’s Moorfields Eye Hospital, one of the world’s leading ophthalmology centres, have voiced serious concern over the leadership of the NHS trust, alleging a “culture of fear” and a ...

A coroner in Surrey has raised concerns about the role of physician associates (PAs) in the NHS in response to the death of a woman with abdominal pain who was wrongly diagnosed as having a nosebleed.

McCartney makes many cogent, well argued points about how potential legislation as a result of a private member’s success is essentially a lottery.1 Like it or not, this is our parliamentary system, ...

Obesity strategy should not be built around a single drug Tirzepatide (Mounjaro) has had a remarkable journey to prominence since its UK marketing authorisation in 2023.1 Approved for glycaemic ...

Andrew studied medicine at Clare College, Cambridge, and St Thomas’ Hospital, London. After house jobs he did national service in Malta and then moved to Edenbridge, Kent, in 1957. Here he worked as a ...

As a doctor with lived experience of an eating disorder, I know that there is a huge amount we can do to educate ourselves better about eating disorders to improve patient care and experiences, writes ...

It’s hard to ignore Donald Trump and the deep harm he’s inflicting on health, both in the US and worldwide (doi:10.1136/bmj.r370 doi:10.1136/bmj.r357 doi:10.1136/bmj.r356 doi:10.1136/bmj.r279 ...

Evidence suggests no increased risk The use of glucagon-like peptide-1 (GLP-1) receptor agonists has surged in recent years, driven by their benefits in glucose control in type 2 diabetes, weight ...

The government’s efforts to tackle antimicrobial resistance (AMR) have had limited impact, the National Audit Office (NAO) has warned. Despite taking the threat seriously, resistant infections have ...